Oral administration of the milk casein-derived tripeptide Val-Pro-Pro attenuates high-fat diet-induced adipose tissue inflammation in mice

British Journal of Nutrition

Volumn 112, Issue 4, 2014, Pages 513-519

  Aihara, Kotaro ^a,b   Osaka, Mizuko ^a   Yoshida, Masayuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Calpis Company Limited   (Japan)

Author keywords

Adipose tissue; Casein derived tripeptides; High fat diet; Inflammation; Macrophages

Indexed keywords

CASEIN; CD18 ANTIGEN; CHEMOKINE RECEPTOR CCR2; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA 18S; TAP WATER; TRIPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALYLPROPYLPROLINE; ANTIINFLAMMATORY AGENT; INTEGRIN; MILK PROTEIN; VALINE PROLINE PROLINE;

18S RRNA GENE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CCL2 GENE; CCR2 GENE; CELL ACTIVATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; IL 6 GENE; INFLAMMATION; LIPID DIET; MACROPHAGE; MALE; MCP 1 GENE; MILK; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STROMA; TNF ALPHA GENE; CHRONIC INFLAMMATION; EPIDIDYMIS FAT; MACROPHAGE MIGRATION; OBESITY;

MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD18; CASEINS; CATTLE; CHEMOKINE CCL2; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; GENE EXPRESSION REGULATION; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; OBESITY; OLIGOPEPTIDES; PANNICULITIS; PEPTIDE FRAGMENTS;

EID: 84905593386     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514001147     Document Type: Article

References (42)

1. Weisberg SP, McCann D, Desai M, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
2. Van Gaal LF, Mertens IL & De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444, 875-880.
3. Guilherme A, Virbasius JV, Puri V, et al. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9, 367-377.
4. Nakamura Y, Yamamoto N, Sakai K, et al. (1995) Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78, 777-783.
5. Mizuno S, Nishimura S, Matsuura K, et al. (2004) Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. J Dairy Sci 87, 3183-3188.
6. Cicero AF, Gerocarni B, Laghi L, et al. (2011) Blood pressure lowering effect of lactotripeptides assumed as functional foods: A meta-analysis of current available clinical trials. J Hum Hypertens 25, 425-436.
7. Cicero AF, Aubin F, Azais-Braesco V, et al. (2013) Do the lactotripeptides isoleucine-proline-proline and valine-prolineproline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am J Hypertens 26, 442-449.
8. Hirota T, Nonaka A, Matsushita A, et al. (2011) Milk caseinderived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings. Heart Vessels 26, 549-556.
9. Hirota T, Ohki K, Kawagishi R, et al. (2007) Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: Contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens Res 30, 489-496.
10. Yoshizawa M, Maeda S, Miyaki A, et al. (2009) Additive beneficial effects of lactotripeptides and aerobic exercise on arterial compliance in postmenopausal women. Am J Physiol Heart Circ Physiol 297, H1899-H1903.
11. Nakamura T, Mizutani J, Ohki K, et al. (2011) Casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro improves central blood pressure and arterial stiffness in hypertensive subjects: A randomized, double-blind, placebo-controlled trial. Atherosclerosis 219, 298-303.
12. Nakamura T, Hirota T, Mizushima K, et al. (2013) Milkderived peptides, Val-Pro-Pro and Ile-Pro-Pro, attenuate atherosclerosis development in apolipoprotein E-deficient mice: A preliminary study. J Med Food 16, 396-403.
13. Aihara K, Ishii H & Yoshida M (2009) Casein-derived tripeptide, Val-Pro-Pro (VPP), modulates monocyte adhesion to vascular endothelium. J Atheroscler Thromb 16, 594-603.
14. Webster GA, Bowles MJ, Karim MS, et al. (1995) Flow cytometric analysis of peripheral blood lymphocyte subset light scatter characteristics as a means of monitoring the development of rat small bowel allograft rejection. Clin Exp Immunol 100, 536-542.
15. Lazarus AH, Ellis J, Blanchette V, et al. (1998) Permeabilization and fixation conditions for intracellular flow cytometric detection of the T-cell receptor zeta chain and other intracellular proteins in lymphocyte subpopulations. Cytometry 32, 206-213.
16. Hagita S, Osaka M, Shimokado K, et al. (2011) Adipose inflammation initiates recruitment of leukocytes to mouse femoral artery: Role of adipo-vascular axis in chronic inflammation. PLoS ONE 6, e19871.
17. Brake DK, Smith EO, Mersmann H, et al. (2006) ICAM-1 expression in adipose tissue: Effects of diet-induced obesity in mice. Am J Physiol Cell Physiol 291, C1232-C1239.
18. Wu H, Perrard XD, Wang Q, et al. (2010) CD11c expression in adipose tissue and blood and its role in diet-induced obesity. Arterioscler Thromb Vasc Biol 30, 186-192.
19. Ito A, Suganami T, Yamauchi A, et al. (2008) Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. J Biol Chem 283, 35715-35723.
20. Kurahara H, Shinchi H, Mataki Y, et al. (2011) Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 167, e211-e219.
21. Komohara Y, Ohnishi K, Kuratsu J, et al. (2008) Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216, 15-24.
22. Patsouris D, Neels JG, Fan W, et al. (2009) Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment. J Biol Chem 284, 31223-31235.
23. Nguyen MT, Favelyukis S, Nguyen AK, et al. (2007) A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 282, 35279-35292.
24. Lumeng CN, Bodzin JL & Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117, 175-184.
25. Cinti S, Mitchell G, Barbatelli G, et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46, 2347-2355.
26. Nishimura S, Manabe I, Nagasaki M, et al. (2007) Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56, 1517-1526.
27. Gordon S & Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5, 953-964.
28. Mantovani A, Sica A, Sozzani S, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25, 677-686.
29. Hernández-Ledesma B, Hsieh CC & de Lumen BO (2013) Chemopreventive properties of Peptide Lunasin: A review. Protein Pept Lett 20, 424-432.
30. Kovacs-Nolan J, Zhang H, Ibuki M, et al. (2012) The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation. Biochim Biophys Acta 1820, 1753-1763.
31. Cam A & de Mejia EG (2012) Role of dietary proteins and peptides in cardiovascular disease. Mol Nutr Food Res 56, 53-66.
32. Wu H, Gower RM, Wang H, et al. (2009) Functional role of CD11c\+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119, 2708-2717.
33. Stout RD, Jiang C, Matta B, et al. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175, 342-349.
34. Lumeng CN, DelProposto JB, Westcott DJ, et al. (2008) Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 57, 3239-3246.
35. Weisberg SP, Hunter D, Huber R, et al. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116, 115-124.
36. Inouye KE, Shi H, Howard JK, et al. (2007) Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 56, 2242-2250.
37. Kirk EA, Sagawa ZK, McDonald TO, et al. (2008) Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]. Diabetes 57, 1254-1261.
38. Nishimura S, Manabe I, Nagasaki M, et al. (2008) In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 118, 710-721.
39. Masuda O, Nakamura Y & Takano T (1996) Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 126, 3063-3068.
40. Satake M, Enjoh M, Nakamura Y, et al. (2002) Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 66, 378-384.
41. Ohsawa K, Satsu H, Ohki K, et al. (2008) Producibility and digestibility of antihypertensive beta-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: Analyses using an in vitro model of mammalian gastrointestinal digestion. J Agric Food Chem 56, 854-858.
42. Kawaguchi K, Nakamura T, Kamiie J, et al. (2012) Accumulation of ACE inhibitory tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in vascular endothelial cells. Biosci Biotechnol Biochem 76, 1792-1795.